Tu double hydrogen artemisinin cure lupus erythematosus (sle) accelerated the achievements

As professor tu and his team of artemisinin research results. Current clinical trial results show that the artemisinin for the treatment of discoid lupus erythematosus (sle) more than 90% efficient, efficient treatment of systemic lupus erythematosus (sle) is more than 80%

Time: 2016-09-22

Source: China's traditional Chinese medicine

Author: Zhao Weiting

The graph is signing ceremony scene.

Report from our correspondent (reporter Zhao Weiting) on September 21st, China institute of traditional Chinese medicine academy of sciences and kunming group co., LTD., has carried on the double hydrogen artemisinin treatment of lupus erythematosus (sle) project signing ceremony. The two sides will work together to promote double hydrogen artemisinin treating lupus erythematosus (sle) clinical trials and achievements. China institute of traditional Chinese medicine academy of sciences, Chen sl and kunming group, put up a representative unit to sign the agreement between the parties.

Tu team found that double hydrogen obvious effects of artemisinin treatment of lupus erythematosus (sle). After the double hydrogen artemisinin treatment of lupus erythematosus (sle) project has passed the state food and drug supervision and management of the administration of examination and approval, the approval documents for drug clinical trials.

, deputy director of the national health and family planning commission, the state administration of traditional Chinese medicine guo-qiang wang said in the signing ceremony, double hydrogen artemisinin treatment of lupus erythematosus (sle) project is professor tu and his team tightly aimed at international medical problems, to research and development of artemisinin, embodies the precious spirit of beginner's mind, never forget to move on.

Guo-qiang wang points out, accelerate the transformation of scientific research achievements is the key to realize scientific and technological innovation, kunming group of traditional Chinese medicine (TCM) and Chinese academy of sciences cooperation to carry out the spirit of national conference on science and technology innovation. The future how to make more Chinese medicine scientific research achievements into products, services, quickly, meet the demand of people's health, you also need to continuously explore Chinese medicine people. The health and the health assembly also emphasise strive to promote the revitalization of the development of Chinese medicine. Kunming group and China academy of traditional Chinese medicine to innovation mechanism, accelerate the process of transformation of scientific research achievements, promote the research and development of artemisinin tu and his team of settled down to, devotion, love to the deep, the spirit of selfless dedication, scaling new heights, the project do well as soon as possible, make traditional Chinese medicine again contribute to human health and well-being.

Academician of China academy of traditional Chinese medicine dean zhang bl is introduced, the existing clinical trial results show that the artemisinin lupus erythematosus (sle) are precise, stable curative effect, treatment of discoid lupus erythematosus (sle) more than 90% efficient, efficient treatment of systemic lupus erythematosus (sle) is more than 80%. Hormone therapy for early disease control lupus erythematosus (sle), and artemisinin has obvious therapeutic effect in the whole pathological process.

The state administration of traditional Chinese medicine, director of the office of Chad Yang Zhaoxiang Wang Siyang kunming group chairman, vice President and artemisinin team staff representatives to attend the meeting.

> > > > news

1973, tu group JiCong artemisinin antimalarial active ingredient found in Chinese traditional medicine artemisinin, the successful synthesis of the first artemisinin derivatives double hydrogen artemisinin, which created a new generation of antimalarial drug artemisinin tablets double hydrogen, in 1992 won the national "a new drug certificate" (92 who pass word X - 66, 66).

Lupus erythematosus (sle) is a kind of refractory autoimmune diseases. Double hydrogen artemisinin for the treatment of lupus erythematosus (sle) is inspired by another antimalarial chloroquine, chloroquine clinically to disk and systemic lupus erythematosus (sle) have certain curative effect, but the long-term use can lead to retinal lesions. Tu group by pharmacological experiments found that hydrogen artemisinin have immunosuppressive effect and can accelerate the immunodeficiency animals' immune function reconstruction. Double hydrogen artemisinin treatment of lupus erythematosus (sle) in 1999 to apply for the Chinese invention patent and authorized.